The immunogenicity of the oka/merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content

Journal of Infectious Diseases

Volumn 162, Issue 5, 1990, Pages 1049-1054

  Bergen, Randy E ^a   Arvin, Ann M ^a   Diaz, Pamela S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ARTICLE; CELLULAR IMMUNITY; CHICKENPOX; CHILD; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; MALE; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; VACCINATION; VARICELLA ZOSTER VIRUS;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHICKENPOX VACCINE; CHILD; COMPARATIVE STUDY; HERPESVIRUS 3, HUMAN; HUMAN; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; PHOSPHOPROTEINS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0025188799     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/162.5.1049     Document Type: Article

References (24)

1. Preblud SR. Age-specific risks of varicella complications. Pediatrics 1981;68:14–17
2. ParyaniSG, Arvin AM. Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med 1986;314:1542–1546
3. Arbeter AM, Starr SE, Preblud SR, Ihara T, Paciorek PM, Miller DS, Zelson CM, Proctor EA, Plotkin SA. Varicella vaccine trials in healthy children: a summary of comparative and follow-up studies. Am J Dis Child 1984;138:434–438
4. Arbeter AM, Starr SE, Weibel RE, Plotkin SA. Live attenuated varicella vaccine: immunization of healthy children with the OKA strain. J Pediatr 1982;100:886–893
5. Weibel RE, Kuter BJ, Neff BJ, Rothenberger CA, Fitzgerald AJ, Connor KA, Morton D, McLean AA, Scolnick EM. Live Oka/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment. JAMA 1985;254:2435–2439
6. Brunell PA, Novelli VM, Lipton SV, Pollock B. Combined vaccine against measles, mumps, rubella, and varicella. Pediatrics 1988;81:779–784
7. Johnson CE, Shurin PA, Fattlar D, Rome LP, Kumar ML. Live attenuated varicella vaccine in healthy 12- to 24-month-old children. Pediatrics 1988;81:512–518
8. Johnson C, Rome LP, Stancin T, Kumar ML. Humoral immunity and clinical reinfections following varicella vaccine in healthy children. Pediatrics 1989;84:418–421
9. Diaz PS, Smith S, Hunter E, Arvin AM. Immunity to whole varicella- zoster virus antigen and glycoproteins I and pl70: relation to the immunizing regimen of live attenuated varicella vaccine. J Infect Dis 1988;158:1245–1252
10. Gershon AA, Steinberg SP, LaRussa P, Ferrara A, Hammerschlag M, Gelb L. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis 1988;158:132–137
11. Gershon AA, Steinberg SP, GelbL, GalassoG, Borkowsky W, LaRussa P, Ferrara A. Live attenuated varicella vaccine: efficacy for children with leukemia in remission. JAMA 1984;252:355–362
12. Gershon AA, Steinberg SP. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N Engl J Med 1989;320:892–897
13. Arvin AM, Kinney-Thomas E, Shriver K, Grose C, Koropchak CM, Scranton E, Wittek AE, Diaz PS. Immunity to varicella-zoster viral glycoproteins gpl (gp90/58)andgpDI(gpll8), and to a nonglycosylated protein, p170. J Immunol 1986;137:1346–1351
14. Davidson M, Krugman S. Recombinant yeast hepatitis B vaccine compared with plasma-derived vaccine: immunogenicity and effect of a booster dose. J Infect 1986;13(suppl A):31–38
15. Salk J, Stoeckel P, Van Wezel AL, Lapinleim K, Van Steenis G. Antigen content of inactivated poliovirus vaccine for use in a one- or two- dose regimen. Ann Clin Res 1982;14:204–212
16. Emini EA, Jameson BA, Wimmer E. Priming for and induction of antipoliovirus neutralizing antibodies by synthetic peptides. Nature 1983;304:699–703
17. Just M, Berger R, Luescher D. Live varicella vaccine in healthy individuals. Postgrad Med J 1985;61(suppl):S129–S132
18. Takahashi M, Hayakawa Y, Shiraki K, Yamanishi K, Asano Y, Ozaki T. Attenuation and laboratory markers of the Oka-strain varicella- zoster virus. Postgrad Med J 1985;61(suppl):S37–S46
19. Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics 1986;78(suppl):748–756
20. Asano Y, Nakayama H, Yazaki T, Kato R, Hirose S, Tsusuki K, Ito S, Takahashi M. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics 1982;59:3–10
21. Brunell PA, Novelli VM, Keller PM, Ellis RW. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response. J Infect Dis 1987;156:430–435
22. Duby L, Steinberg SP, LaRussa P, Oh P, Gershon AA. Antibody to varicella-zoster virus: analysis by Western blot. J Infect Dis 1988; 157:882–888
23. Diaz PS, Smith S, Hunter E, Arvin AM. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. J Immunol 1989;142:636–641
24. Hiller R, Winistorfer S, Grose C. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects. J Infect Dis 1989;160:919–928